ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

CRDF Cardiff Oncology Inc

3.50
-0.98 (-21.87%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cardiff Oncology Inc CRDF NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.98 -21.87% 3.50 23:00:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.96 3.12 4.42 3.52 4.48
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:05GLOBECardiff Oncology Reports First Quarter 2024 Results and..
25/4/202415:05GLOBECardiff Oncology to Report First Quarter 2024 Results and..
08/4/202415:05GLOBECardiff Oncology Presents Novel Preclinical Data at AACR..
07/3/202417:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202417:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:05GLOBECardiff Oncology Announces Upcoming Presentations at the..
29/2/202415:07GLOBECardiff Oncology Reports Fourth Quarter and Full Year 2023..
29/2/202415:06GLOBECardiff Oncology Provides Clinical Update on Phase 2..
29/2/202415:05GLOBECardiff Oncology Announces First Patient Dosed in Randomized..
29/2/202415:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202407:00GLOBECardiff Oncology to Present at the Cowen 44th Annual Health..
22/2/202407:00GLOBECardiff Oncology to Report Fourth Quarter and Full Year 2023..
06/2/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202409:30PRNUSCardiff Oncology Announces Publication of Data from Phase 1b..
08/1/202408:12EDGAR2Form 8-K - Current report
20/11/202315:05PRNUSCardiff Oncology to Present at the 35th Annual Piper Sandler..
02/11/202315:06EDGAR2Form 8-K - Current report
02/11/202315:05PRNUSCardiff Oncology Reports Third Quarter 2023 Results and..
02/11/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202315:05PRNUSCardiff Oncology to Report Third Quarter 2023 Financial..
26/9/202315:07EDGAR2Form 8-K - Current report
26/9/202315:05PRNUSCardiff Oncology Announces Positive Clinical Data in..
05/9/202307:00PRNUSCardiff Oncology to Present at Upcoming Investor Conferences..
09/8/202315:06EDGAR2Form 8-K - Current report
09/8/202315:05PRNUSCardiff Oncology Reports Second Quarter 2023 Results and..
09/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202315:42EDGAR2Form 8-K - Current report
07/8/202315:05PRNUSCardiff Oncology Announces New Lead Program in First-Line..
24/7/202316:13EDGAR2Form 8-K - Current report
24/7/202316:09PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
20/6/202316:22PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
05/6/202307:00PRNUSCardiff Oncology to Present at the Jefferies Healthcare..

Su Consulta Reciente

Delayed Upgrade Clock